Cytostatic drug combinations in the treatment of metastatic cancer of the breast
Svennevig, J.L.; Wennberg, J.E.; Bernstein, O.; Lange, J.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 95(32): 1854-1855; 1866
1975
ISSN/ISBN: 0029-2001 PMID: 1198566 Document Number: 87122
Document emailed within 1 workday
Related Documents
Klaassen, U.; Seeber, S. 1997: Metastatic breast cancer: treatment with fluorouracil-based combinations Oncology 11(9 Suppl 10: 69-73Garin, A.M.; Dmitrieva, N.V.; Vyshinskaia, G.V.; Lichintser, M.R. 1987: Rational combinations of hormonal and cytostatic agents in disseminated forms of breast cancer Voprosy Onkologii 33(11): 13-17
Pouillart, P.; Schwarzenberg, L.; Palangie, T.; Belpomme, D.; Mathé, G.; Huguenin, P.; Morin, P.; Gautier, H.; Laparre, C.; Baron, A. 1976: Combination chemotherapy in the treatment of polymetastic breast cancer. Comparison of therapeutic effects of 2 methods of sequential drug administration. Role of adriamycin in these combinations La Nouvelle Presse Medicale 5(9 Oct 76: 2145-2150
Cerea, G.; Vaghi, M.; Ardizzoia, A.; Villa, S.; Bucovec, R.; Mengo, S.; Gardani, G.; Tancini, G.; Lissoni, P. 2003: Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations Anticancer Research 23(2c): 1951-1954
Balázs, M.; Tüske, M. 1986: Polychemotherapeutic treatment of patients with metastatic breast cancer Acta Medica Hungarica 43(4): 407-411
Allegra, C.J.; Egan, G.F.; Drake, J.C.; Steinberg, S.M.; Swain, S.M. 1988: The treatment of metastatic breast cancer with 5-fluorouracil and leucovorin Advances in Experimental Medicine and Biology 244: 107-112
Liu, X.; Song, S.; Guan, Z.; Wu, S.; Duan, Y.; Yu, J.; Yang, L. 2002: Capecitabine (xeloda) in the treatment of relapsed and metastatic breast cancer Zhonghua Zhong Liu Za Zhi 24(1): 71-73
Hayes, D.F.; Henderson, I.C.; Shapiro, C.L. 1995: Treatment of metastatic breast cancer: present and future prospects Seminars in Oncology 22(2 Suppl 5: 5
Moĭseenko, V.M.; Orlova, R.V.; Ermakova, N.A.; Protsenko, S.A. 2000: Treatment with Miltex for metastatic skin lesions in breast cancer Voprosy Onkologii 46(5): 600-603
Kovalev, A.A.; Tsvetaeva, D.A.; Grudinskaja, T.V. 2013: Role of ABC-cassette transporters (MDR1, MRP1, BCRP) in the development of primary and acquired multiple drug resistance in patients with early and metastatic breast cancer Experimental Oncology 35(4): 287-290
Brehmer, B.; Hossfeld, D.K.; Kersting, D. 1977: Combined surgical and cytostatic therapy in patients with advanced metastatic nonseminomatous testicular cancer Der Urologe. Ausg. a 16(6): 331-333
Chagpar, A.B. 2007: Insights into the management of locally advanced, inflammatory, and metastatic breast cancer: highlights from the 2007 Louisville Breast Cancer Update Journal of the Kentucky Medical Association 105(11): 559-560
Koukourakis, G.; Kouloulias, V.; Zacharias, G.; Koukourakis, M. 2010: Capecitabine chemotherapy for metastatic colorectal cancer. Chemical structure, combinations and efficacy Journal of Buon: Official Journal of the Balkan Union of Oncology 15(4): 652-659
Holmes, F.A. 1996: Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review Seminars in Oncology 23(5 Suppl 11: 46-56
Baltali, Eşmen.; Altundağ, M.Kadri.; Güler, Nüfer.; Ozişik, Y.; Firat, Dçer.; Baran, I.; Tekuzman, Gülten. 2002: Paclitaxel and doxorubicin combination in the first-line treatment of metastatic breast cancer Tumori 88(3): 200-203
Rosset, G.; Barrelet, L.; Alberto, P. 1975: Palliative treatment of metastatic breast cancer with diethyldioxystilbene diphosphate (Honvan) Schweizerische Medizinische Wochenschrift 105(43): 1388-1390
Kashiwagi, S.; Ishihara, S.; Asano, Y.; Kurata, K.; Tauchi, Y.; Tokumoto, M.; Morisaki, T.; Noda, S.; Kawajiri, H.; Takashima, T.; Onoda, N.; Hirakawa, K. 2014: Eribulin chemotherapy after taxane treatment in advanced metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 41(12): 1951-1953
Gebauer, G.; Jäger, W.; Lang, N. 1998: mRNA expression of components of the insulin-like growth factor system in breast cancer cell lines, tissues, and metastatic breast cancer cells Anticancer Research 18(2a): 1191-1195
Holmes, F.A.; Yap, H.Y.; Esparza, L.; Buzdar, A.U.; Hortobagyi, G.N.; Blumenschein, G.R. 1984: Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer Seminars in Oncology 11(3 Suppl 1: 28-31
Matter, M.; Dusmet, M.; Chevalley, F. 2000: The place of surgery in the treatment of advanced localized, recurrent and metastatic breast cancer Revue Medicale de la Suisse Romande 120(6): 485-490